Yuyu Pharma unveiled the results of its mechanism of action and head-to-head studies for its dry eye treatment peptide (project name: YP-P10). The results showed that YP-P10 had better efficacy than several competing dry eye treatment products such as Lifitegrast, Cyclosporine, Diquafosol, and Hyaluronic Acid.
Yuyu Pharm. Inc.
Category:
SME
Main Business Area
Manufacturing, fabricating, or processing of drugs
| Contact Details | Yuyu Building, 197 Dongho-ro, Jung-gu, Seoul (Sindang-dong)TEL: 02-2253-6600 |
|---|
Find out more companies
Related products
-
-
-
-
SMEALTEOGEN Inc.
ALTEOGEN Inc. is a leading bio company whose portfolio includes next-generation biobetters, biosimilars, and proprietary biologics. They are focusing on three cutting-edge areas of the industry – long-acting biobetters, proprietary antibody-drug conjugate (ADC), and antibody biosimilars with high complexity.
-
